The function of untranslated (UT) nucleotide sequences in the proximal portion of the pX region of the human T-cell leukemia virus (HTLV) family of retroviruses remains enigmatic. Previous studies have shown that these sequences are not necessary for the expression of viral proteins or for the induction, transmission, or maintenance of the transformed cell type in vitro. To determine the effect of the UT region in vivo, separate groups of rabbits were inoculated with lethally irradiated, stable clones of the human Blymphoblastoid cell line, 729, transfected with either a fulllength wild-type HTLV-II clone (pH6neo) or a mutant clone containing a 324-bp deletion in the proximal UT portion of pX (pH6neoAUl'l6661-69841). or nontransfected 729 cells. All rabbits inoculated with either wild-type or pX-deleted HTLV-II developed a similar profile and titer of serum antibodies against HTLV-II antigens, as determined by Western immunoblots, by 4 weeks postinoculation (PI). Antibody titers, as determined by enzyme immunoassay, were similar between the t w o groups of rabbits and increased over the
18-week period of study. All rabbits were killed at 18 weeks PI, and spleen, peripheral blood lymphocytes (PBMC), bone marrow, and mesenteric lymph node were assayed for HTLV-II taxhex sequences by quantitative polymerase chain reaction. Virus was detected in all tissues tested from all rabbits inoculated with 729pH6neo cells containing wildtype HTLV-II, which contained between 1.4 and 0.3 mean copies of provirus per cell. In contrast, the distribution and number of provirus copies were more limited in rabbits inoculated with 729pH6neoAUT(6661-6984) cells containing UTdeleted HTLV-II; in most tissues, there was a fivefold t o sevenfold reduction in mean provirus copies per cell as compared with rabbits inoculated with wild-type HTLV-II. All rabbits inoculated with control 729 cells remained negative for HTLV-II infection, as determined by the same techniques. It was concluded that UT sequences in the proximal portion of HTLV-II are not necessary for infection but confer increased replicative capacity in vivo. 0 1996 b y The American Society of Hematology.
typical of other retroviruses, the HTLVs contain an approximately 1.6-kilobase (kb) 3' region originally designated pX that encodes nonstructural viral regulatory proteins.lO,"
These structural and functional characteristics are shared by simian T-cell leukemia virus" and bovine leukemia virus (BLV),I3 which are also classified as members of the HTLV family of retroviruses.
Four open reading frames (ORFs), designated pX-I, pX-11, pX-111, and pX-IV, were initially identified within the HTLV-I pX The second coding exon of the transacting viral proteins Tax and Rex are expressed from the overlapping ORFs pX-IV and pX-111, respectively, and are translated from a doubly spliced, bicistronic mRNA. Tax increases the rate of viral transcription by activating the viral promoter in the viral long terminal repeat,16"* while Rex acts posttranscriptionally to increase the ratio of incompletely spliced mRNAs to doubly spliced mRNA.'9-' ' The function of ORFs x-I and x-I1 contained in the proximal portion of pX remains less well known. This region, consisting of 655 base pairs (bp) and 573 bp for HTLV-I and HTLV-11, respectively, has been referred to as the nontranslated or untranslated (UT) region, because it is not known to be expressed, or as the nonconserved region, because the nucleotide sequence homology between the two viruses is poorly conserved (28%).22-25 Recently, alternatively spliced mRNAs and protein isoforms encoded in the pX region have been identified for HTLV-I,""" HTLV-II,3" and BLV."." However, analysis of HTLV-I and -11 UT deletion mutants have shown that these sequences are not necessary for successful induction, transmission, or maintenance of the transformed cell type or in vitro expression of tux, rex, or env.32-3s
We and others have previously shown that rabbits are susceptible to infection with HTLV-I and HTLV-II.'h~'X In the current study, we have taken advantage of this animal model and the availability of HTLV-I1
clones containing wild-type p r~v i r u s~~.~'~~" and UT to elucidate the function of the proximal pX region in vivo. 
MATERIALS AND METHODS

E.stublishment qf HTLV-II-tranrfected cell lines.
The 729pH6neo cells were derived by transfection of the Epstein-Barr virus (EBV)-transformed human B-lymphoblastoid cell line, 729, with a wildtype HTLV-I1 clone, pH6neo.'"".'" Plasmid DNAs were introduced into 729 cells by electroporation, as described previously." A total of S X IOh cells and 25 pg of plasmid DNA were exposed to a 960-pF charge with a 250-V potential, and stable transfectants were isolated by selection in G41 8. The 729pH6neoAUT cells were derived by transfection of 729 cells with the HTLV-II clone pH6neo-AUT(6661-6984). which contains a 324-bp deletion in the proximal UT portion of pX between Pstl sites at nucleotides (nts) 6661 and 6984." The deletion of the 324 nts of the S' portion of the UT sequences removes the three previously identified splice acceptor sites. Therefore, this deletion prevents the production of all previously identified messages. Transfected cells were cloned by limiting dilution and assessed for proviral load by Southern analysis4' and for p19 and p24 expression by indirect immunofluorescence?
Inoculation of rabbits. The procedure for infection of rabbits with HTLV-I1 has been described previo~sly..'~ Briefly, three groups of four (two males and two females per group) weanling (8-week-old) New Zealand white rabbits (Western Oregon Rabbit CO, Philomath, OR) were inoculated intravenously with 1 X IO7 lethally irradiated (SS Gy), uninfected 729 cells (rabbits 1 through 4). HTLV-11-infected 729pH6neo cells (rabbits S through 8). or 729pH6neoAUT(6661-6984) cells (rabbits 9 through 12). Aliquots of each cellular inoculum were maintained in culture to confirm lethality of irradiation and to measure HTLV-II p24 expression by enzyme immunoassay (Coulter Immunology, Hialeah, FT) in 3-day culture supernatants.
Detection of anti-HTLV-II antibodies. Serum antibody response to HTLV-II was determined by Western immunoblot as previously describeda3 using a commercially prepared HTLV-11,"-infected cell lysate (Hillcrest Biologicals, Cypress, CA) as target antigen, sera diluted I : 100, and biotinylated goat anti-rabbit IgG, strepavidinhorseradish peroxidase conjugate (Kirkegaard and Perry Labs, Gaithersburg, MD), and diaminobenzidine-nickel chloride-hydrogen peroxide for detection. Specificity of the antibody reactivity was verified with anti-HTLV-I1 p24 monoclonal antibody and serum from a confirmed HTLV-11-infected patient. Antibody titers to HTLV-II were determined with an enzyme immunoassay according to the manufacturer's instructions (Vironostika HTLV-I Microelisa System: Organon Teknika, Durham, NC). Sera from HTLV-11-infected patients has been shown to react with HTLV-I antigens."
Detection sf HTLV-II antigens. Density gradient-isolated peripheral blood lymphocytes (PBMC) and single-cell suspensions of tissues collected at necropsy (spleen, mesenteric lymph node, and bone marrow) were cultured alone or with equal numbers of 3-day mitogen-stimulated control rabbit PRMC (2 X IO"/mL final concentration), as described previo~sly.'~ Cells and culture supernatants were harvested after 7 days, freeze-thawed to rupture cells, clarified by centrifugation, and assayed for HTLV-II p24 by enzyme immunoassay as above.
Detection of HTLV-II proviral sequences. PBMC and tissues collected at necropsy were assayed hy polymerase chain reaction (PCR) for HTLV-11 gene regions, as previously de~cribed'~ with modifications. Briefly, genomic DNA was isolated by sodium dodecy1 sulfate (SDS)-proteinase K treatment and phenol and chloroform extraction. Two primer pairs were included in each reaction: HTLV . Taq polymerase and sample DNA were then added in buffer, and samples were heated to 91°C for 3 minutes and 65°C for S minutes to complete the first cycle; an additional 29 cycles were performed at 91°C for 1 minute and 65°C for 2 minutes. To confirm that the products were specific for HTLV-11, an aliquot of the amplified product was digested with Taql to yield a labeled 86-bp fragment: Nondigested and digested reaction products were electrophoresed in polyacrylamide gels, which were then fixed and exposed to X-ray film. Autoradiographs were digitized for densitometric analysis (Scan Analysis; Biosoft, Ferguson, MO) and quantified based on Comparison with the actin signal. Titrations of HTLV-11-positive 729pH6neo and 729pH6neo-AUT(6661-6984) cell DNA were included in each PCR run. Only signals that fell in the linear response range of control dilutions were used for quantitation.
RESULTS
In vitro analvsis of HTLV-ll-transfected cells.
The infectivity of the wild-type and deleted clones was tested after transfection and isolation of 729 lymphoblastoid producer cell lines. Both the wild-type pH6neo and the deletion mutant man PBMC and to induce syncytia in BJAB cells with equal efficiency has been reported previously.'' Serologic and clinicopatldogic response of rabbits. All rabbits receiving wild-type or deleted HTLV-11-infected cells seroconverted to HTLV-I1 by 4 weeks postinoculation (PI) and remained seropositive, as determined by Western immunoblot, over the 18 weeks of the study (Fig 1) . Antibody reactivity occurred against both gag and env antigens, and the intensity of the response increased with time PI. The pattern of antibody reactivity did not differ between rabbits receiving full-length versus deleted virus. Rabbits inoculated with uninfected. control 729 cells did not develop anti-HTLV-I1 antibodies. There was no difference in terminal ( 1 8 weeks PI) serum antibody titers, as determined by enzyme immunoassay, between rabbits receiving full-length versus deleted virus (Fig 2) . In general, the intensity of Western immunoblot reactivity (Fig 1) correlated with enzyme-linked immunosorbent assay (ELISA) antibody titer (Fig 2) for individual rabbits. Differences in serologic responses detected by these two assays were most likely due to differences in the composition and concentration of viral antigens and sensitivity of the assays. No evidence of disease, as manifested by differences in weight gain, hematologic profiles, or the gross or microscopic characteristics of tissues at necropsy, occurred in rabbits in any group.
Detection qf HTLV-I1 antigens. All cultures of PBMC, spleen, mesenteric lymph node, and bone marrow, either alone or cocultured with normal rabbit PBMC, from rabbits in all groups were negative for HTLV-I1 p24, as determined by antigen capture immunoassay.
Detection of HTLV-I1 proviral sequences. Experiments were first conducted to determine the sensitivity and specificity of the PCR conditions. As few as 15 copies of HTLV-I1 t d r e x gene could be detected (based on signal detected using 0.1 ng of cellular DNA containing one copy of virus per cell), the sensitivity of detection was identical between DNA from 729pH6neo cells containing wild-type virus and 729pH6neoAUT(6661-6984) cells containing deleted virus, and the production of amplified product was linear over a 100-fold range of target DNA (Fig 3A) . Linearity was retained when both actin and fadrex target sequences were coamplified (Fig 3B) . The level of sensitivity was independent of the total cellular DNA contained in the reaction mix (data not shown). Taql restriction endonuclease digestion of the 159-bp product amplified from either 729pH6neo or 729pH6neoAUT(666 1-6984) DNA yielded the expected 86-bp fragment, confirming specificity of the HTLV-II tcdrex amplification (data not shown).
Tissues collected at the termination of the study ( 18 weeks PI) were analyzed by PCR. DNA was extracted from PBMC, bone marrow, spleen, and mesenteric lymph node and amplified with both S' end-labeled HTLV-I1 tdre.x and actin primers (Fig 4) . less readily detectable in tissues from rabbits inoculated with 729pH6neoAUT(6661-6984) cells containing deleted HTLV-11. This occurred despite similar amounts of target DNA, as evidenced by the intensity of actin product amplified from tissues of rabbits in both groups. All tissues from rabbits inoculated with uninfected 729 cells were negative for fnx/re.r product.
Estimates of proviral load in each tissue collected at the termination of the study were derived by densitometric analysis of digitized autoradiographs of PCR results, based on the amount of actin product coamplified in the same reaction and assuming two copies of actin per diploid cell (Fig S) . In rabbits inoculated with 729pH6neo cells, provirus was most abundant in PBMC (mean. 1.4 copies per cell), followed by mesenteric lymph node and bone marrow (mean, 0.6 copies per cell for each) and spleen (mean, 0.3 copies per cell). In most tissues from rabbits inoculated with 729pH6neoAUT(6661-6984) cells, there was a fivefold to sevenfold reduction in the mean number of provirus copies per cell as compared with PBMC of rabbits inoculated with wild-type virus.
DISCUSSION
The evolutionary conservation of the UT region in HTLV-I and HTLV-I1 suggests that these sequences confer some biologic advantage for the viruses. Until recently, however, suitable animal models and viral clones were not available to investigate the biologic significance of this region in vivo. We chose to study HTLV-I1 because of newly developed molecular clones that enabled a comparison of the effect of wild-type and UT-deleted provi~ses,'".",'gJ" and because we had already demonstrated the infectivity of the wild-type clone in rabbits3' Furthermore, stable cell clones transfected with wild-type HTLV-I1 provirus or UT-deletion mutants have been shown to be indistinguishable in terms of viral protein production, reverse transcriptase activity, and ability to induce syncytia in suitable target cells or to transform primary human T lymphocytes in vitro. 35 The results of the current study extend these findings by demonstrating that both wild-type and UT-deleted HTLV-I1 proviral clones are able to infect susceptible rabbits in vivo. Importantly. however, the tissue distribution and amount of provirus were markedly increased in rabbits inoculated with the wild-type clone as compared with the deleted clone. These results provide strong evidence that the proximal pX region contains elements that enhance viral replication in vivo and may thereby influence the biologic outcome of infection. For
org From
Results of infection of rabbits with molecularly cloned HTLV-I1 reported here are similar to those previously described.17 Rabbits inoculated with either wild-type or UTdeleted HTLV-I1 developed an early and persistent antiviral antibody response, including reactivity against both gag and env antigens, and produced minimal viral antigen in vitro despite the presence of PCR-detectable provirus in a variety of tissues. While the ability of wild-type and deleted virus to infect and transform the appropriate target cells are indistinguishable in vitro, the deleted virus replicated less efficiently in rabbits, as evidenced by a lower proviral load in tissues as compared with tissues from rabbits inoculated with the wild-type virus. Such differences in replication, however, were not reflected by differences in viral antigen production in vitro or in the anti-viral antibody responses elicited in vivo between the two groups of rabbits.
The function of ORFs x-I and x-I1 in the UT pX region remains unknown. Novel viral mRNAs from this region have recently been described for HTLV-I, HTLV-11, and ORF x-I contains sequences that encode a p12' protein corresponding to the two-thirds C-terminal amino acids of a putative protein called Rof (pX-rex-ORF I). ORF x-I1 contains sequences encoding putative proteins p30", also called Tof (pX-tax-ORF 11), and ~1 3 " . Using cDNAtransfected cells and polyclonal rabbit antisera or monoclonal antibodies raised against peptides derived from putative amino acid sequences, p12', p13", and p30" were localized to three different cellular compartments, representing endomembranes, nuclei, and nucleoli, respectively." Each of these mRNAs has been detected in freshly isolated cells from HTLV-I-infected human patients,*' suggesting a possible role in HTLV-associated disease progression, but there is no evidence that the corresponding protein products are expressed in vivo." The similarity in amino acid sequences between HTLV-I and HTLV-I1 Rof and p12' putative protein^'^ suggests that if proteins are expressed from ORFs x-l and x-I1 in vivo, they would serve similar functions for both viruses.
Our finding that both wild-type and UT-deleted molecular clones of HTLV-I1 are infectious for rabbits supports results from other studies showing that the UT region is dispensable for the biologic effects of HTLV-I and HTLV-I1 in vitro32"5: however, the greater proviral load in rabbits infected with wild-type as compared with pX-deleted HTLV-I1 viruses indicates that the UT region confers increased viral replicative capacity in vivo. Similar findings were recently reported in sheep experimentally infected with BLV containing deletions in the R3 and G4 ORFS.~' The effect of these deletions on induction of disease in either HTLV-infected rabbits or BLV-infected sheep remains to be determined. Analogous studies with simian immunodeficiency virus (SIV) showed that deletion of sequences in the auxiliary nefgene had no effect on virus replication in vitro, but resulted in marked reduction of virus load and abrogation of pathogenic potential when tested in adult macaques.J6 More recent studies have demonstrated that nef-deleted SIV retains its pathogenicity when tested in neonatal macaques: ' illustrating the importance of host factors in determining the final outcome of infection.
Despite evidence of increased viral replication in rabbits ~~~, 2 7 -7 1 infected with the wild-type HTLV-I1 virus, no evidence of disease occurred in any rabbits over the 18-week period of this study. This observation is similar to previous findings in rabbits experimentally infected with HTLV-13'.'' or HTLV-II.37 It has been suggested that the detection of alternatively spliced mRNAs correlates with the stage of disease in BLV-infected cattle.3' However, definitive protein products or other nonprotein-encoding functions of the UT region that might have pathogenic significance have yet to be described for HTLV-I, HTLV-11, or BLV. The further use of animal models in which differences in viral replication not discernable in vitro are readily demonstrable in vivo will be critical to our increased understanding of the pathogenesis of the HTLVs. Future studies should be directed toward elucidating differences in replication between wild-type and UT-deleted mutants, including cell types that are infected and the interaction between viral regulatory proteins and cellular transcription-activating proteins that control viral replication. 
